- Ivermectin Impurity G
-
- $0.00 / 10mg
-
2025-12-19
- CAS:73162-95-5
- Min. Order: 10mg
- Purity: 90%+
- Supply Ability: 10g
- Ivermectin impurity 8
-
- $0.00 / 5mg
-
2025-12-19
- CAS:73162-95-5
- Min. Order: 5mg
- Purity: 95%+
- Supply Ability: 1000mg
|
| | IverMectin B1 Aglycon Basic information |
| Product Name: | IverMectin B1 Aglycon | | Synonyms: | IverMectin B1 Aglycon;XOCXXEYUGYTCNG-ZTOWVSLKSA-N;Ivermectin EP impurity G;Ivermectin Impurity 7(Ivermectin EP Impurity G);Ivermectin Impurity G;22,23-dihydroavermectin B1 aglycone;Milbemycin B, 5-O-demethyl-28-deoxy-6,28-epoxy-13-hydroxy-25-[(1S)-1-methylpropyl]-, (6R,13S,25R)-;Ivermectin Impurity G(EP) | | CAS: | 73162-95-5 | | MF: | C34H50O8 | | MW: | 586.76 | | EINECS: | | | Product Categories: | | | Mol File: | 73162-95-5.mol |  |
| | IverMectin B1 Aglycon Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble | | form | A solid |
| | IverMectin B1 Aglycon Usage And Synthesis |
| Description | Ivermectin B1a aglycone is an acid degradation product produced by hydrolysis of the disaccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. | | Uses | Ivermectin B1a aglycone is an acid degradation product produced by hydrolysis of the disaccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity.[Cayman Chemical] | | References | [1] JOHN C. CHABALA. Ivermectin, a new broad-spectrum antiparasitic agent[J]. Journal of Medicinal Chemistry, 1980, 23 10: 1134-1136. DOI: 10.1021/jm00184a014 |
| | IverMectin B1 Aglycon Preparation Products And Raw materials |
|